1-3 of 3
Reynaldo Garcia, RN, OCN
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Results of a Phase I Study of Vorinostat In Combination with Pegylated Liposomal Doxorubicin and Bortezomib In Patients with Relapsed/Refractory Multiple Myeloma

Peter M Voorhees, M.D., Cristina Gasparetto, MD, Keren Osman, MD, Kristy Richards, PhD, MD, Madlyn Ferraro, RN, OCN, CCRC, Reynaldo Garcia, RN, OCN, Jennifer MacLean, RN, Diane Winans, Dominic Moore, PhD, John Strader, Robert Z. Orlowski, MD, PhD, David Duane Hurd, MD
Journal: Blood
Blood (2010) 116 (21): 1955.
https://doi.org/10.1182/blood.V116.21.1955.1955
Published: 2010
Journal Articles

Phase I Study of the Novel Surivin and cdc2/CDK1 Inhibitor Terameprocol in Patients with Advanced Leukemias.

Raoul Tibes, MD, PhD, Kevin T. McDonagh, MD, Lazaros Lekakis, MD, Neal Frazer, MD, Scott Mohrland, PhD, Bassett Dawn, RN, Reynaldo Garcia, RN, OCN, Katy Schroeder, RN, Vijayalakshmi Shanmugam, John Carpten, Daniel Von Hoff, MD, FACP, Thomas C. Shea, MD
Journal: Blood
Blood (2009) 114 (22): 1039.
https://doi.org/10.1182/blood.V114.22.1039.1039
Published: 2009
Journal Articles

Vorinostat in Combination with Pegylated Liposomal Doxorubicin and Bortezomib for Patients with Relapsed/Refractory Multiple Myeloma: Results of a Phase I Study.

Peter M. Voorhees, MD, Cristina Gasparetto, MD, Kristy L. Richards, PhD, MD, Reynaldo Garcia, RN, OCN, John S. Strader, Madlyn Ferraro, RN, OCN, CCRC, Jennifer MacLean, RN, Diane Winans, Dominic T. Moore, PhD, Andrew Dodd, Matthew C. Foster, MD, Don A. Gabriel, MD, PhD, Thomas C. Shea, Jonathan Serody, MD, Hendrik W. van Deventer, MD, Syed Rizvi, Robert Z. Orlowski, M.D., Ph.D., David D. Hurd, MD
Journal: Blood
Blood (2009) 114 (22): 306.
https://doi.org/10.1182/blood.V114.22.306.306
Published: 2009